Risk Factors for Mortality of Inpatients with Pseudomonas aeruginosa Bacteremia in China: Impact of Resistance Profile in the Mortality
Yulin Zhang,1 Yi Li,2 Ji Zeng,3 Yanzi Chang,4 Shouhua Han,5 Jiankang Zhao,1 Yanyan Fan,1 Zhujia Xiong,1 Xiaohui Zou,1 Chunlei Wang,1 Binbin Li,1 Haibo Li,1 Jiajing Han,1 Xinmeng Liu,1 Yudi Xia,1 Binghuai Lu,1 Bin Cao1,6,7 1Department of Pulmonary and Critical Care Medicine, Laboratory of Clinical Mi...
Main Authors: | , , , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2020-11-01
|
Series: | Infection and Drug Resistance |
Subjects: | |
Online Access: | https://www.dovepress.com/risk-factors-for-mortality-of-inpatients-with-pseudomonas-aeruginosa-b-peer-reviewed-article-IDR |
id |
doaj-dbea5d8964264431b129c77fb0ecbfc6 |
---|---|
record_format |
Article |
spelling |
doaj-dbea5d8964264431b129c77fb0ecbfc62020-11-25T04:05:32ZengDove Medical PressInfection and Drug Resistance1178-69732020-11-01Volume 134115412359225Risk Factors for Mortality of Inpatients with Pseudomonas aeruginosa Bacteremia in China: Impact of Resistance Profile in the MortalityZhang YLi YZeng JChang YHan SZhao JFan YXiong ZZou XWang CLi BLi HHan JLiu XXia YLu BCao BYulin Zhang,1 Yi Li,2 Ji Zeng,3 Yanzi Chang,4 Shouhua Han,5 Jiankang Zhao,1 Yanyan Fan,1 Zhujia Xiong,1 Xiaohui Zou,1 Chunlei Wang,1 Binbin Li,1 Haibo Li,1 Jiajing Han,1 Xinmeng Liu,1 Yudi Xia,1 Binghuai Lu,1 Bin Cao1,6,7 1Department of Pulmonary and Critical Care Medicine, Laboratory of Clinical Microbiology and Infectious Diseases, Center for Respiratory Diseases, National Clinical Research Center of Respiratory Diseases, China-Japan Friendship Hospital, Beijing 100029, People’s Republic of China; 2Department of Laboratory Medicine, Henan Provincial People’s Hospital, Zhengzhou, People’s Republic of China; 3Department of Laboratory Medicine, Wuhan Pu Ai Hospital of Huazhong University of Science and Technology, Wuhan, People’s Republic of China; 4Department of Laboratory Medicine, Ningbo Medical Center Lihuili Hospital, Ningbo, People’s Republic of China; 5Department of Laboratory Medicine, Weifang No.2 People’s Hospital, Weifang, People’s Republic of China; 6Clinical Center for Pulmonary Infections, Capital Medical University, Beijing, People’s Republic of China; 7Tsinghua University-Peking University, Joint Center for Life Sciences, Beijing, People’s Republic of ChinaCorrespondence: Binghuai Lu; Bin CaoDepartment of Pulmonary and Critical Care Medicine, Laboratory of Clinical Microbiology and Infectious Diseases, Center for Respiratory Diseases, National Clinical Research Center of Respiratory Diseases, China-Japan Friendship Hospital, Chaoyang District, Beijing 100029, People’s Republic of ChinaTel/Fax +86-10-84206257Email zs25041@126.com; caobin_ben@163.comPurpose: Pseudomonas aeruginosa bacteremia presents a severe challenge to hospitalized patients. However, to date, the risk factors for mortality among inpatients with P. aeruginosa bacteremia in China remain unclear.Patients and Methods: This retrospective multicenter study was performed to analyze 215 patients with culture-confirmed P. aeruginosa bacteremia in five healthcare centers in China during the years 2012– 2019.Results: Of 215 patients with P. aeruginosa bacteremia, 61 (28.4%) died during the study period. Logistic multivariable analysis revealed that cardiovascular disease (OR=3.978, P=0.001), blood transfusion (OR=5.855, P< 0.001) and carbapenem-resistant P. aeruginosa (CRPA) phenotype (OR=4.485, P=0.038) constituted the independent risk factors of mortality. Furthermore, both CRPA and multidrug-resistant P. aeruginosa (MDRPA) phenotypes were found to be significantly associated with 5-day mortality (Log-rank, P< 0.05).Conclusion: This study revealed a high mortality rate amongst hospitalized patients with P. aeruginosa bacteremia, and those with cardiovascular diseases, CRPA and MDRPA phenotypes, should be highlighted and given appropriate management in China.Keywords: risk factors, mortality, Pseudomonas aeruginosa, bacteremiahttps://www.dovepress.com/risk-factors-for-mortality-of-inpatients-with-pseudomonas-aeruginosa-b-peer-reviewed-article-IDRrisk factorsmortalitypseudomonas aeruginosabacteremia. |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Zhang Y Li Y Zeng J Chang Y Han S Zhao J Fan Y Xiong Z Zou X Wang C Li B Li H Han J Liu X Xia Y Lu B Cao B |
spellingShingle |
Zhang Y Li Y Zeng J Chang Y Han S Zhao J Fan Y Xiong Z Zou X Wang C Li B Li H Han J Liu X Xia Y Lu B Cao B Risk Factors for Mortality of Inpatients with Pseudomonas aeruginosa Bacteremia in China: Impact of Resistance Profile in the Mortality Infection and Drug Resistance risk factors mortality pseudomonas aeruginosa bacteremia. |
author_facet |
Zhang Y Li Y Zeng J Chang Y Han S Zhao J Fan Y Xiong Z Zou X Wang C Li B Li H Han J Liu X Xia Y Lu B Cao B |
author_sort |
Zhang Y |
title |
Risk Factors for Mortality of Inpatients with Pseudomonas aeruginosa Bacteremia in China: Impact of Resistance Profile in the Mortality |
title_short |
Risk Factors for Mortality of Inpatients with Pseudomonas aeruginosa Bacteremia in China: Impact of Resistance Profile in the Mortality |
title_full |
Risk Factors for Mortality of Inpatients with Pseudomonas aeruginosa Bacteremia in China: Impact of Resistance Profile in the Mortality |
title_fullStr |
Risk Factors for Mortality of Inpatients with Pseudomonas aeruginosa Bacteremia in China: Impact of Resistance Profile in the Mortality |
title_full_unstemmed |
Risk Factors for Mortality of Inpatients with Pseudomonas aeruginosa Bacteremia in China: Impact of Resistance Profile in the Mortality |
title_sort |
risk factors for mortality of inpatients with pseudomonas aeruginosa bacteremia in china: impact of resistance profile in the mortality |
publisher |
Dove Medical Press |
series |
Infection and Drug Resistance |
issn |
1178-6973 |
publishDate |
2020-11-01 |
description |
Yulin Zhang,1 Yi Li,2 Ji Zeng,3 Yanzi Chang,4 Shouhua Han,5 Jiankang Zhao,1 Yanyan Fan,1 Zhujia Xiong,1 Xiaohui Zou,1 Chunlei Wang,1 Binbin Li,1 Haibo Li,1 Jiajing Han,1 Xinmeng Liu,1 Yudi Xia,1 Binghuai Lu,1 Bin Cao1,6,7 1Department of Pulmonary and Critical Care Medicine, Laboratory of Clinical Microbiology and Infectious Diseases, Center for Respiratory Diseases, National Clinical Research Center of Respiratory Diseases, China-Japan Friendship Hospital, Beijing 100029, People’s Republic of China; 2Department of Laboratory Medicine, Henan Provincial People’s Hospital, Zhengzhou, People’s Republic of China; 3Department of Laboratory Medicine, Wuhan Pu Ai Hospital of Huazhong University of Science and Technology, Wuhan, People’s Republic of China; 4Department of Laboratory Medicine, Ningbo Medical Center Lihuili Hospital, Ningbo, People’s Republic of China; 5Department of Laboratory Medicine, Weifang No.2 People’s Hospital, Weifang, People’s Republic of China; 6Clinical Center for Pulmonary Infections, Capital Medical University, Beijing, People’s Republic of China; 7Tsinghua University-Peking University, Joint Center for Life Sciences, Beijing, People’s Republic of ChinaCorrespondence: Binghuai Lu; Bin CaoDepartment of Pulmonary and Critical Care Medicine, Laboratory of Clinical Microbiology and Infectious Diseases, Center for Respiratory Diseases, National Clinical Research Center of Respiratory Diseases, China-Japan Friendship Hospital, Chaoyang District, Beijing 100029, People’s Republic of ChinaTel/Fax +86-10-84206257Email zs25041@126.com; caobin_ben@163.comPurpose: Pseudomonas aeruginosa bacteremia presents a severe challenge to hospitalized patients. However, to date, the risk factors for mortality among inpatients with P. aeruginosa bacteremia in China remain unclear.Patients and Methods: This retrospective multicenter study was performed to analyze 215 patients with culture-confirmed P. aeruginosa bacteremia in five healthcare centers in China during the years 2012– 2019.Results: Of 215 patients with P. aeruginosa bacteremia, 61 (28.4%) died during the study period. Logistic multivariable analysis revealed that cardiovascular disease (OR=3.978, P=0.001), blood transfusion (OR=5.855, P< 0.001) and carbapenem-resistant P. aeruginosa (CRPA) phenotype (OR=4.485, P=0.038) constituted the independent risk factors of mortality. Furthermore, both CRPA and multidrug-resistant P. aeruginosa (MDRPA) phenotypes were found to be significantly associated with 5-day mortality (Log-rank, P< 0.05).Conclusion: This study revealed a high mortality rate amongst hospitalized patients with P. aeruginosa bacteremia, and those with cardiovascular diseases, CRPA and MDRPA phenotypes, should be highlighted and given appropriate management in China.Keywords: risk factors, mortality, Pseudomonas aeruginosa, bacteremia |
topic |
risk factors mortality pseudomonas aeruginosa bacteremia. |
url |
https://www.dovepress.com/risk-factors-for-mortality-of-inpatients-with-pseudomonas-aeruginosa-b-peer-reviewed-article-IDR |
work_keys_str_mv |
AT zhangy riskfactorsformortalityofinpatientswithpseudomonasaeruginosabacteremiainchinaimpactofresistanceprofileinthemortality AT liy riskfactorsformortalityofinpatientswithpseudomonasaeruginosabacteremiainchinaimpactofresistanceprofileinthemortality AT zengj riskfactorsformortalityofinpatientswithpseudomonasaeruginosabacteremiainchinaimpactofresistanceprofileinthemortality AT changy riskfactorsformortalityofinpatientswithpseudomonasaeruginosabacteremiainchinaimpactofresistanceprofileinthemortality AT hans riskfactorsformortalityofinpatientswithpseudomonasaeruginosabacteremiainchinaimpactofresistanceprofileinthemortality AT zhaoj riskfactorsformortalityofinpatientswithpseudomonasaeruginosabacteremiainchinaimpactofresistanceprofileinthemortality AT fany riskfactorsformortalityofinpatientswithpseudomonasaeruginosabacteremiainchinaimpactofresistanceprofileinthemortality AT xiongz riskfactorsformortalityofinpatientswithpseudomonasaeruginosabacteremiainchinaimpactofresistanceprofileinthemortality AT zoux riskfactorsformortalityofinpatientswithpseudomonasaeruginosabacteremiainchinaimpactofresistanceprofileinthemortality AT wangc riskfactorsformortalityofinpatientswithpseudomonasaeruginosabacteremiainchinaimpactofresistanceprofileinthemortality AT lib riskfactorsformortalityofinpatientswithpseudomonasaeruginosabacteremiainchinaimpactofresistanceprofileinthemortality AT lih riskfactorsformortalityofinpatientswithpseudomonasaeruginosabacteremiainchinaimpactofresistanceprofileinthemortality AT hanj riskfactorsformortalityofinpatientswithpseudomonasaeruginosabacteremiainchinaimpactofresistanceprofileinthemortality AT liux riskfactorsformortalityofinpatientswithpseudomonasaeruginosabacteremiainchinaimpactofresistanceprofileinthemortality AT xiay riskfactorsformortalityofinpatientswithpseudomonasaeruginosabacteremiainchinaimpactofresistanceprofileinthemortality AT lub riskfactorsformortalityofinpatientswithpseudomonasaeruginosabacteremiainchinaimpactofresistanceprofileinthemortality AT caob riskfactorsformortalityofinpatientswithpseudomonasaeruginosabacteremiainchinaimpactofresistanceprofileinthemortality |
_version_ |
1724433466614874112 |